Biotech

All Articles

Bain reveals $3B fund forever science business

.Along with a tough performance history for identifying diamonds in the rough, Bain Resources Daily ...

Genentech's cancer cells restructure created 'for clinical reasons'

.The latest choice to merge Genentech's two cancer cells divisions was actually produced "medical fa...

Tern oral GLP-1 shows 5% weight-loss at 1 month at greatest dosage

.Terns Pharmaceuticals' selection to drop its own liver condition aspirations may yet settle, after ...

Merck, Daiichi replay early success in little mobile lung cancer with updated ADC records

.Merck &amp Co.'s long-running attempt to land a hit on small cell lung cancer cells (SCLC) has scor...

Boehringer, Bayer breakthrough lung cancer drugs towards Astra war

.Some clients with non-small tissue lung cancer cells (NSCLC) have mutations in a gene referred to a...

MBX pursues $136M IPO to take opponent to Ascendis into phase 3

.MBX has expanded strategies to consume over $136 thousand from its own IPO as the biotech tries to ...

Relay boob cancer cells information tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has hammered its survival goal in a first-in-human boob cancer cells study, sett...

AZ outlines AI-enabled TROP2 biomarker technique for Daiichi ADC

.AstraZeneca has used expert system to design a special biomarker for its Daiichi Sankyo-partnered d...

AstraZeneca IL-33 medication stops working to enhance COPD breathing in ph. 2

.AstraZeneca managers claim they are "certainly not anxious" that the breakdown of tozorakimab in a ...

BMS veterinarian solutions Foghorn's call for CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, shooting...